NCT05935917View on ClinicalTrials.gov

Study Evaluating the Bioequivalence of Brincidofovir Form H and Form II Tablets in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

May 30, 2023

Primary Completion Date

August 14, 2023

Study Completion Date

September 27, 2023

Conditions
Smallpox
Interventions
DRUG

Brincidofovir

100 mg tablet of Form H and 100 mg tablet of Form II

Trial Locations (1)

66212

Altasciences, Overland Park

Sponsors
All Listed Sponsors
lead

Emergent BioSolutions

INDUSTRY